D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVTA
1326
DELISTED
Avantax, Inc. Common Stock
AVTA
| $9.89M | 0.01% |
387,503
-128,729
| -25% | -$2.95M |
|
|
ACCD
1327
DELISTED
Accolade Inc
ACCD
| $9.89M | 0.01% |
1,269,558
+308,026
| +32% | +$2.94M |
|
1328
Viridian Therapeutics
VRDN
$2.13B
| $9.88M | 0.01% |
338,167
-290,108
| -46% | -$6.68M |
|
1329
Mitsubishi UFJ Financial
MUFG
$258B
| $9.87M | 0.01% |
1,480,252
+94,843
| +7% | +$491K |
|
1330
Mercury Insurance
MCY
$5.94B
| $9.87M | 0.01% |
288,538
+236,447
| +454% | +$7.86M |
|
|
NRAC
1331
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
| $9.86M | 0.01% |
975,975
+114,769
| +13% | +$1.15M |
|
1332
PUT
Suncor Energy
SU
$77.7B
| $9.85M | 0.01% |
310,700
-865,800
| -74% | -$28.5M |
|
1333
CALL
Steel Dynamics
STLD
$35.6B
| $9.85M | 0.01% |
100,800
+15,500
| +18% | +$1.49M |
|
1334
Quest Diagnostics
DGX
$25.1B
| $9.84M | 0.01% |
62,930
+21,562
| +52% | +$3.1M |
|
|
SLCA
1335
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $9.84M | 0.01% |
786,863
+31,929
| +4% | +$409K |
|
1336
Wheaton Precious Metals
WPM
$50.6B
| $9.82M | 0.01% |
251,300
-13,175
| -5% | -$476K |
|
1337
Travere Therapeutics
TVTX
$5.33B
| $9.82M | 0.01% |
466,840
+90,997
| +24% | +$1.93M |
|
|
JBTM
1338
JBT Marel
JBTM
$7.14B
| $9.81M | 0.01% |
107,380
+77,334
| +257% | +$7.08M |
|
|
QFTA
1339
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
| $9.79M | 0.01% |
974,352
| – | – |
|
1340
First Financial Bankshares
FFIN
$4.97B
| $9.79M | 0.01% |
284,595
-18,590
| -6% | -$703K |
|
1341
PUT
Coherent
COHR
$55.2B
| $9.76M | 0.01% |
278,100
+132,700
| +91% | +$4.61M |
|
1342
Coursera
COUR
$1.54B
| $9.76M | 0.01% |
824,844
+164,269
| +25% | +$2.07M |
|
1343
PUT
Macy's
M
$6.15B
| $9.75M | 0.01% |
472,000
-19,200
| -4% | -$393K |
|
1344
Alliant Energy
LNT
$19.4B
| $9.72M | 0.01% |
176,045
-177,278
| -50% | -$9.47M |
|
|
NFNT
1345
DELISTED
Infinite Acquisition Corp.
NFNT
| $9.71M | 0.01% |
947,630
| – | – |
|
|
SPKB
1346
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
| $9.71M | 0.01% |
962,214
+965
| +0.1% | +$9.65K |
|
|
BGSX
1347
DELISTED
Build Acquisition Corp.
BGSX
| $9.69M | 0.01% |
967,031
| – | – |
|
1348
CALL
XPeng
XPEV
$11.8B
| $9.68M | 0.01% |
974,200
+765,000
| +366% | +$6.9M |
|
1349
JELD-WEN Holding
JELD
$94.8M
| $9.67M | 0.01% |
1,002,584
+264,759
| +36% | +$2.57M |
|
|
MRTX
1350
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.66M | 0.01% |
213,301
-353,129
| -62% | -$22.9M |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.